
Genmab A/S
CSE:GMAB

Genmab A/S?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 363.5
2 126
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Genmab A/S hold over its rivals?
What risks and challenges
does Genmab A/S face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Genmab A/S.
Provide an overview of the primary business activities
of Genmab A/S.
What unique competitive advantages
does Genmab A/S hold over its rivals?
What risks and challenges
does Genmab A/S face in the near future?
Summarize the latest earnings call
of Genmab A/S.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Genmab A/S.
Provide P/S
for Genmab A/S.
Provide P/E
for Genmab A/S.
Provide P/OCF
for Genmab A/S.
Provide P/FCFE
for Genmab A/S.
Provide P/B
for Genmab A/S.
Provide EV/S
for Genmab A/S.
Provide EV/GP
for Genmab A/S.
Provide EV/EBITDA
for Genmab A/S.
Provide EV/EBIT
for Genmab A/S.
Provide EV/OCF
for Genmab A/S.
Provide EV/FCFF
for Genmab A/S.
Provide EV/IC
for Genmab A/S.
Show me price targets
for Genmab A/S made by professional analysts.
What are the Revenue projections
for Genmab A/S?
How accurate were the past Revenue estimates
for Genmab A/S?
What are the Net Income projections
for Genmab A/S?
How accurate were the past Net Income estimates
for Genmab A/S?
What are the EPS projections
for Genmab A/S?
How accurate were the past EPS estimates
for Genmab A/S?
What are the EBIT projections
for Genmab A/S?
How accurate were the past EBIT estimates
for Genmab A/S?
Compare the revenue forecasts
for Genmab A/S with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Genmab A/S and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Genmab A/S against its competitors.
Analyze the profit margins
(gross, operating, and net) of Genmab A/S compared to its peers.
Compare the P/E ratios
of Genmab A/S against its peers.
Discuss the investment returns and shareholder value creation
comparing Genmab A/S with its peers.
Analyze the financial leverage
of Genmab A/S compared to its main competitors.
Show all profitability ratios
for Genmab A/S.
Provide ROE
for Genmab A/S.
Provide ROA
for Genmab A/S.
Provide ROIC
for Genmab A/S.
Provide ROCE
for Genmab A/S.
Provide Gross Margin
for Genmab A/S.
Provide Operating Margin
for Genmab A/S.
Provide Net Margin
for Genmab A/S.
Provide FCF Margin
for Genmab A/S.
Show all solvency ratios
for Genmab A/S.
Provide D/E Ratio
for Genmab A/S.
Provide D/A Ratio
for Genmab A/S.
Provide Interest Coverage Ratio
for Genmab A/S.
Provide Altman Z-Score Ratio
for Genmab A/S.
Provide Quick Ratio
for Genmab A/S.
Provide Current Ratio
for Genmab A/S.
Provide Cash Ratio
for Genmab A/S.
What is the historical Revenue growth
over the last 5 years for Genmab A/S?
What is the historical Net Income growth
over the last 5 years for Genmab A/S?
What is the current Free Cash Flow
of Genmab A/S?
Discuss the annual earnings per share (EPS)
trend over the past five years for Genmab A/S.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
DK |
![]() |
Genmab A/S
CSE:GMAB
|
86.6B DKK | 4 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 36 547 712.8 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
370.7B USD | 6.6 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
169.7B USD | 5.1 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
133.4B USD | 4.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.3B USD | 11.7 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 927.6 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
123B AUD | 5.1 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
72.2B USD | 5.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 18.6 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
36.6B USD | 16.3 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
DK |
![]() |
Genmab A/S
CSE:GMAB
|
Average P/S:
3 322 701.6
4
|
14%
|
0.3 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
36 547 712.8
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.6
|
8%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
5.1
|
4%
|
1.3 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.6
|
3%
|
1.5 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.7
|
10%
|
1.2 |
|
US |
E
|
Epizyme Inc
F:EPE
|
1 927.6
|
N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
5.1
|
7%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
5.1
|
7%
|
0.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
18.6
|
30%
|
0.6 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
16.3
|
28%
|
0.6 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.